C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma

Annals of Surgical Oncology

Volumn 20, Issue 8, 2013, Pages 2699-2705

  Ohtsuka, Masahisa ^a   Yamamoto, Hirofumi ^a   Masuzawa, Toru ^a   Takahashi, Hidekazu ^a   Uemura, Mamoru ^a   Haraguchi, Naotsugu ^a   Nishimura, Junichi ^a   Hata, Taishi ^a   Yamasaki, Makoto ^a   Miyata, Hiroshi ^a   Takemasa, Ichiro ^a   Mizushima, Tsunekazu ^a   Takiguchi, Shuji ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C4 4A PROTEIN; GLYCOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CYTOPLASM; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; OVERALL SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL MEMBRANE; CYTOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GLYCOSYLPHOSPHATIDYLINOSITOLS; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880278288     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2900-2     Document Type: Article

References (25)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
2. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17:2-9.
3. Taccioli C, Chen H, Jiang Y, et al. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene. 2012;31:4550-8.
4. Matzku S, Wenzel A, Liu S, Zoller M. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res. 1989;49:1294-9.
5. Claas C, Herrmann K, Matzku S, Moller P, Zoller M. Developmentally regulated expression of metastasis-associated antigens in the rat. Cell Growth Differ. 1996;7:663-78.
6. Rosel M, Claas C, Seiter S, Herlevsen M, Zoller M. Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene. 1998;17:1989-2002.
7. Wurfel J, Seiter S, Stassar M, et al. Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene. 2001;262:35-41.
8. Smith BA, Kennedy WJ, Harnden P, Selby PJ, Trejdosiewicz LK, Southgate J. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res. 2001;61:1678-85.
9. Hansen LV, Gardsvoll H, Nielsen BS, et al. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem J. 2004;380(Pt 3):845-57.
10. Seiter S, Stassar M, Rappl G, Reinhold U, Tilgen W, Zoller M. Upregulation of C4.4A expression during progression of melanoma. J Invest Dermatol. 2001;116:344-7.
11. Fletcher GC, Patel S, Tyson K, et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4A and dystroglycan. Br J Cancer. 2003;88:579-85.
12. Hansen LV, Skov BG, Ploug M, Pappot H. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Lung Cancer. 2007;58:260-6.
13. Paret C, Hildebrand D, Weitz J, et al. C4.4A as a candidate marker in the diagnosis of colorectal cancer. Br J Cancer. 2007;97:1146-56.
14. Konishi K, Yamamoto H, Mimori K, et al. Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer. Cancer Sci. 2010;101:2269-77.
15. Oshiro R, Yamamoto H, Takahashi H, et al. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer. Cancer Sci. 2012;103:1155-64.
16. Yamamoto H, Oshiro R, Ohtsuka M, et al. Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2013;42:197-201.
17. Hayashi N, Yamamoto H, Hiraoka N, et al. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology. 2001;34(4 Pt 1):638-50.
18. Noura S, Yamamoto H, Ohnishi T, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol. 2002;20:4232-41.
19. Takemasa I, Yamamoto H, Sekimoto M, et al. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res. 2000;60:3043-50.
20. Yamamoto H, Soh JW, Shirin H, et al. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene. 1999;18:103-15.
21. Hansen LV, Laerum OD, Illemann M, Nielsen BS, Ploug M. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer. 2008;122:734-41.
22. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681-92.
23. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851-6.
24. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (jcog9907). Ann Surg Oncol. 2012;19:68-74.
25. Esselens CW, Malapeira J, Colome N, Moss M, Canals F, Arribas J. Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17. Biol Chem. 2008;389:1075-84.